416 The oral HDAC inhibitor SB939 shows activity in in vitro and in vivo models of acute myeloid leukemia von Diermayr, V, Ong, L.C, Loh, Y.K, Cheong, A, Hart, S, Goh, K.C, Hentze, H.H, Wang, H, Ethirajulu, K.E, Wood, J.M

Volltext

83 POSTER A robust and quantitative biomarker assay for SB939, a potent, orally-active HDAC inhibitor von Novotny-Diermayr, V, Nayagam, V.M, Hentze, H.H, Liang, A.L, Loh, Y.K, Sausgruber, N, Yeo, P, Ethirajulu, K, Wood, J.M

Volltext